Nisa Investment Advisors
SRTA

Nisa Investment Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Nisa Investment Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.2K Sell
15,791
-675
-4% -$3.55K ﹤0.01% 1639
2026
Q1 		$68.8K Buy
16,466
+11,679
+244% +$56.2K ﹤0.01% 1555
2025
Q4 		$23K Hold
4,787
– – ﹤0.01% 1887
2025
Q3 		$24.2K Hold
4,787
– – ﹤0.01% 1914
2025
Q2 		$19.3K Buy
4,787
+4,096
+593% +$13.3K ﹤0.01% 1960
2025
Q1 		$1.89K Buy
691
+271
+65% +$972 ﹤0.01% 2485
2024
Q4 		$1.78K Hold
420
– – ﹤0.01% 2523
2024
Q3 		$1.24K Buy
420
+234
+126% +$745 ﹤0.01% 2526
2024
Q2 		$647 Buy
186
+108
+138% +$360 ﹤0.01% 2626
2024
Q1 		$222 Sell
78
-6,870
-99% -$21.2K ﹤0.01% 2621
2023
Q4 		$24.5K Sell
6,948
-8,932
-56% -$25.6K ﹤0.01% 1819
2023
Q3 		$41.1K Hold
15,880
– – ﹤0.01% 1782
2023
Q2 		$62.6K Buy
15,880
+6,810
+75% +$21.6K ﹤0.01% 1672
2023
Q1 		$31K Buy
9,070
+7,740
+582% +$31.6K ﹤0.01% 1858
2022
Q4 		$5K Hold
1,330
– – ﹤0.01% 2293
2022
Q3 		$5K Buy
+1,330
New +$6.83K ﹤0.01% 2283

Other funds holding SRTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Nisa Investment Advisors's SRTA Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Strata Critical Medical Inc (SRTA) stake by 4.1% in Q2 2026, selling an estimated $3.55K and leaving 15,791 shares worth $83.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Nisa Investment Advisors first reported a position in SRTA in Q3 2022 and has held it in 16 quarters since. 49 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Nisa Investment Advisors held 15,791 shares of Strata Critical Medical Inc worth $83.2K as of Q2 2026.
  • Nisa Investment Advisors sold 675 Strata Critical Medical Inc shares in Q2 2026, an estimated $3.55K.
  • Strata Critical Medical Inc made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1639 holding.
  • Nisa Investment Advisors first reported a position in Strata Critical Medical Inc in Q3 2022 and has held it in 16 quarters since.
  • 49 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.